Home-based pulmonary rehabilitation early after hospitalisation in COPD: A randomised controlled trial
European Respiratory Journal · 19.11.2026 · 2600985
DOI: 10.1183/13993003.00985-2026 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Respiratory Journal, online erschienen am 19.11.2026. Verfasst von Narelle S. Cox und 16 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council.
Themen: COPD
Abstract (Originalsprache)
Rationale
COPD is characterised by respiratory exacerbations, often requiring hospitalisation. Post-hospitalisation pulmonary rehabilitation (PR) can reduce risk of readmission, but very few people attend PR post exacerbation.
Objective
To compare hospital readmission rates between people with COPD who undertake a home-based PR program commenced early (≤2 weeks) after hospital discharge (ePR) with usual care.
Methods
Assessor blinded, multi-centre RCT. Participants randomised 1:1 to ePR or usual care. ePR was 8 weeks (1 physiotherapy home-visit, plus 7x weekly phone calls). The primary outcome was all-cause, non-elective hospitalisation at 12 months after rehabilitation completion.
Results
From Jan 2020-Jun 2024 157 participants were randomised to ePR (n=77) or usual care (n=80). The ITT analysis included 151 participants (n=73 ePR, n=78 usual care; n=6 excluded: n=5 deceased, n=1 transplant). Rate of all-cause non-elective hospitalisation was not different between groups at 12-month follow-up (ePR 60.3%, usual care 64.1%; RR 0.94 [95%CI 0.73, 1.21]). There was no difference between groups for improvements in quality of life and breathlessness at either time point. There was a clinically and statistically significant reduction in anxiety favouring ePR (10-weeks post-discharge MD −2.1 [95%CI −3.4, −0.8]; 12-months MD −1.6 [95%CI −3.0, −0.2]). ePR completion rate (≥70% sessions) was high (n=57, 74%). When compared to no rehabilitation (per protocol), ePR completers demonstrated significant improvements in breathlessness, quality of life, anxiety/depression and self-efficacy. There was one intervention-related adverse event. Conclusion ePR delivered directly to patients in their homes, commenced within 2 weeks of hospital discharge, did not reduce hospital readmissions over 12 months compared to usual care but did support high program completion. When compared to no rehabilitation, improved clinical outcomes favoured ePR in those who completed the program.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Cox, N. S., May, A. K., Burge, A. T., Hepworth, G., McDonald, C. F., O'Halloran, P., Mahal, A., Lahham, A., Bondarenko, J., Spencer, L., McNamara, R. J., Crute, H., Gavin, S., Melinz, J., Rawlings, S., Elliott, M., & Holland, A. E. (2026). Home-based pulmonary rehabilitation early after hospitalisation in COPD: A randomised controlled trial. European Respiratory Journal, 2600985. https://doi.org/10.1183/13993003.00985-2026
Vancouver
Cox NS, May AK, Burge AT, Hepworth G, McDonald CF, O'Halloran P, et al. Home-based pulmonary rehabilitation early after hospitalisation in COPD: A randomised controlled trial. European Respiratory Journal. 2026:2600985. doi:10.1183/13993003.00985-2026
BibTeX
@article{Cox2026,
author = {Cox, Narelle S. and May, Anthony K. and Burge, Angela T. and Hepworth, Graham and McDonald, Christine F. and O'Halloran, Paul and Mahal, Ajay and Lahham, Aroub and Bondarenko, Janet and Spencer, Lissa and McNamara, Renae J. and Crute, Hayley and Gavin, Samantha and Melinz, Joanna and Rawlings, Sarah and Elliott, Melissa and Holland, Anne E.},
title = {Home-based pulmonary rehabilitation early after hospitalisation in COPD: A randomised controlled trial},
journal = {European Respiratory Journal},
year = {2026},
pages = {2600985},
doi = {10.1183/13993003.00985-2026}
}
EUVIMED